Your browser doesn't support javascript.
loading
Genetically-engineered "all-in-one" vaccine platform for cancer immunotherapy.
Wu, Aihua; Chen, Yingzhi; Wang, Hairui; Chang, Ya; Zhang, Meng; Zhao, Pengfei; Tang, Yisi; Xu, Qin; Zhu, Zhuangzhi; Cao, Yang; Huang, Yongzhuo.
Afiliación
  • Wu A; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Chen Y; Artemisinin Research Center, the First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510450, China.
  • Wang H; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Chang Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Zhang M; Artemisinin Research Center, the First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510450, China.
  • Zhao P; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Tang Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Xu Q; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Zhu Z; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Cao Y; Artemisinin Research Center, the First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510450, China.
  • Huang Y; Artemisinin Research Center, the First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510450, China.
Acta Pharm Sin B ; 11(11): 3622-3635, 2021 Nov.
Article en En | MEDLINE | ID: mdl-34900541

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Acta Pharm Sin B Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Acta Pharm Sin B Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos